Previous Close | 7.03 |
1-Year Change | -61.37% |
6-Months Change | -64.49% |
3-Months Change | -21.89% |
Moving Avg (50d) | 8.122 |
Moving Avg (200d) | 14.0935 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.752B |
Beta (3-Years) | 1.95 |
Revenue Growth (ttm) | 2502.26% |
Net Profit Margin (ttm) | -68.15% |
Return On Assets (ttm) | -14.86% |
EPS (ttm) | -0.6 |
PE Ratio (ttm) | -11.72 |
Dividend Yield | % |
Asset Description: | bluebird bio, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-02-03 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
7.171 | 7.382 | 7.522 | 7.733 | 8.085 | 8.436 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.